Bahrain Mumtalakat Holding Co. BSC(c) (“Mumtalakat”), the sovereign wealth fund of the Kingdom of Bahrain, announced a strategic partnership with SandboxAQ, a global artificial intelligence and quantum techniques. The collaboration aims to catalyse a cutting-edge biotech ecosystem in Bahrain.

Under the partnership, Bahrain will license SandboxAQ’s software and expertise in quantitative AI to identify and develop novel therapeutics. The initiative is expected to generate over $1 billion in value for the Kingdom through new biotech assets.

The joint effort will position Bahrain as a regional biotech hub. A research committee will guide a three-year program focused on developing valuable new drugs.

HE Shaikh Abdulla bin Khalifa Al Khalifa, CEO of Mumtalakat, said the partnership marks a milestone in diversifying Bahrain’s economy and fostering a thriving health sector. He highlighted that combining national resources with SandboxAQ’s AI expertise will lay the foundation for innovation in health and economic growth.

Jack Hidary, CEO of SandboxAQ, added that the collaboration will harness AI to accelerate drug discovery and attract investment to the Kingdom.

This partnership aligns with Mumtalakat’s ongoing strategy to optimize, enhance, and diversify its portfolio, ensuring sustainable long-term financial returns.

Key Points:

• Bahrain partners with SandboxAQ to develop biotech assets worth $1B+
• AI-driven research to identify new therapeutics over a three-year program
• Initiative aims to position Bahrain as a regional biotech hub

Related post

View all